Anteris Technologies Global Corp. (AVR:NASDAQ) closed at $5.87 on October 23, 2026, down 2.17% on the day. The stock trades 46.9% below its 52-week high of $11.06 and 77.9% above its 52-week low of $3.30. Over the past year, it gained 17.4%. Anteris Technologies Global Corp. is part of the Technology sector.
In 252 trading sessions since October 23, 2025, AVR closed higher on 119 days (47%). Its best day was December 18, 2025 (+15.40%) and its worst was October 24, 2025 (-10.55%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 1 time.
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing innovative medical devices designed to improve the quality of life for patients with aortic stenosis. Our lead product, the DurAVR® transcatheter heart valve ("THV") system, represents a unique product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Our DurAVR® THV System consists of a single-piece, biomimetic valve made with our proprietary ADAPT® tissue-enhancing technology and depoloyed with our ComASUR® balloon-expahndable delivery system. ADAPT® is our proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
Find more stocks like AVR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.